Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Mon, 14.04.2025
Rosenbauer International AG
Company Name:
Rosenbauer International AG
ISIN:
AT0000922554
Reason for the research:
Update
Recommendation:
BUY
from:
14.04.2025
Target price:
EUR 55.00
Target price on sight of:
12 months
Last rating change:
Analyst:
Christian Sandherr
Turnaround achieved // strong final FY24 results; chg. est.Topic: Rosenbauer released stro [ … ]
Mon, 14.04.2025
Almonty Industries Inc
Company Name:
Almonty Industries Inc
ISIN:
CA0203981034
Reason for the research:
Research Report (Initial Coverage)
Recommendation:
Buy
Target price:
4.20 EUR
Target price on sight of:
31.12.2025
Last rating change:
Analyst:
Matthias Greiffenberger, Cosmin Filker
Following years of disciplined capital deployment and strategic [ … ]
Wed, 09.04.2025
Multitude SE
Company Name:
Multitude SE
ISIN:
CH1398992755
Reason for the research:
Update
Recommendation:
BUY
from:
09.04.2025
Target price:
EUR 12.00
Target price on sight of:
12 months
Last rating change:
Analyst:
Frederik Jarchow
Strong FY24: Delivered as promised and more to come; chg
Last week, Multitude reported a particularly stron [ … ]
Mon, 07.04.2025
UmweltBank AG
Company Name:
UmweltBank AG
ISIN:
DE0005570808
Reason for the research:
Research Comment
Recommendation:
Buy
Target price:
10.40 EUR
Target price on sight of:
31.12.2025
Last rating change:
Analyst:
Cosmin Filker, Marcel Goldmann
You can download the research here: http://www.more-ir.de/d/32192.pdf
Contact for questions:
GBC [ … ]
Mon, 07.04.2025
Borussia Dortmund GmbH & Co KGaA
Company Name:
Borussia Dortmund GmbH & Co KGaA
ISIN:
DE0005493092
Reason for the research:
Update
Recommendation:
BUY
from:
07.04.2025
Target price:
EUR 5.20
Target price on sight of:
12 months
Last rating change:
Analyst:
Philipp Sennewald
Prize money distribution for CWC released; chg.
It was about time, but 10 weeks bef [ … ]
Fri, 04.04.2025
Energiekontor AG
Company Name:
Energiekontor AG
ISIN:
DE0005313506
Reason for the research:
Update
Recommendation:
Buy
from:
04.04.2025
Target price:
103,00 Euro
Target price on sight of:
12 Monate
Last rating change:
18.10.2022: Hochstufung von Hinzufügen auf Kaufen
Analyst:
Dr. Karsten von Blumenthal
First Berlin Equity Research hat ein [ … ]
Fri, 04.04.2025
LION E-Mobility AG
Company Name:
LION E-Mobility AG
ISIN:
CH0560888270
Reason for the research:
Update
Recommendation:
BUY
from:
04.04.2025
Target price:
EUR 3.20
Target price on sight of:
12 months
Last rating change:
Analyst:
Christian Sandherr
Weak Q4 prelims, op. trough should have passed; chg.FY24 preliminary sales came in at a mere € [ … ]
Thu, 03.04.2025
Pharming Group NV
Company Name:
Pharming Group NV
ISIN:
NL0010391025
Reason for the research:
Q4/24 results/pipeline expansion
Recommendation:
Buy
from:
03.04.2025
Target price:
€2.30
Target price on sight of:
12 months
Last rating change:
-
Analyst:
Simon Scholes, CFA
First Berlin Equity Research has published a research update on Pharmin [ … ]
Wed, 02.04.2025
Rakovina Therapeutics Inc.
Company Name:
Rakovina Therapeutics Inc.
ISIN:
CA75103L1013
Reason for the research:
Initiation of coverage
Recommendation:
Buy
from:
02.04.2025
Target price:
0,40 CAD
Target price on sight of:
12 Months
Last rating change:
-
Analyst:
Alexander RIhane
First Berlin Equity Research hat am 02.04.2025 die Coverage von Rakovina The [ … ]
Tue, 01.04.2025
Lisata Therapeutics Inc
Company Name:
Lisata Therapeutics Inc
ISIN:
US1280583022
Reason for the research:
Update
Recommendation:
Buy
from:
01.04.2025
Target price:
USD 15.00
Target price on sight of:
12 months
Last rating change:
-
Analyst:
Christian Orquera
First Berlin Equity Research has published a research update on Lisata Therapeutics, Inc. (IS [ … ]
